Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
about
Discovery of Novel Irreversible Inhibitors of Interleukin (IL)-2-inducible Tyrosine Kinase (Itk) by Targeting Cysteine 442 in the ATP PocketNongenomic actions of adrenal steroids in the central nervous system.Functional interactions between steroid hormones and neurotrophin BDNFCrosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatasesMinireview: latest perspectives on antiinflammatory actions of glucocorticoids.Transcriptional regulation of kinases downstream of the T cell receptor: another immunomodulatory mechanism of glucocorticoids.FOXO1-dependent up-regulation of MAP kinase phosphatase 3 (MKP-3) mediates glucocorticoid-induced hepatic lipid accumulation in miceDynamic modulation of thymic microRNAs in response to stress.Genomic and non-genomic actions of glucocorticoids in asthmaInterleukin-13 receptor alpha 2-targeted glioblastoma immunotherapy.CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Gene expression alterations in immune system pathways in the thymus after exposure to immunosuppressive chemicals.Prednisolone exerts exquisite inhibitory properties on platelet functions.The importance of biological oscillators for hypothalamic-pituitary-adrenal activity and tissue glucocorticoid response: coordinating stress and neurobehavioural adaptation.Rapid Glucocorticoid Feedback Inhibition of ACTH Secretion Involves Ligand-Dependent Membrane Association of Glucocorticoid Receptors.Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expressionGlucocorticoid receptor: implications for rheumatic diseases.Immunotherapy in glioblastoma: emerging options in precision medicineGlucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-gamma signaling for glutamate release via a glutamate transporter.CD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infectionAdoptive transfer of virus-specific and tumor-specific T cell immunityThe regulation of the mitochondrial apoptotic pathway by glucocorticoid receptor in collaboration with Bcl-2 family proteins in developing T cellsThe HPA - Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain.The role of high-dose corticosteroids in the treatment of chronic lymphocytic leukemia.Asthma therapy and its effect on airway remodelling.Can side effects of steroid treatments be minimized by the temporal aspects of delivery method?Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.Impact of Immune-Modulatory Drugs on Regulatory T Cell.Covalent incorporation and controlled release of active dexamethasone from injectable polyethylene glycol hydrogels.Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.Heterogeneity of glucocorticoid resistance in patients with bronchial asthmaThe type I interferon signaling pathway is a target for glucocorticoid inhibition.Mitochondrial translocation of the glucocorticoid receptor in double-positive thymocytes correlates with their sensitivity to glucocorticoid-induced apoptosis.Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors.Human lymphocyte activation assay: an in vitro method for predictive immunotoxicity testing.Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines.Immunosuppressants and alloimmunization against red blood cell transfusions.High-sensitivity immunofluorescence staining: a comparison of the liposome procedure and the FASER technique on mGR detection.Virus-drug interactions--molecular insight into immunosuppression and HCV.
P2860
Q27679513-82654A94-E20F-4DC7-B41E-8722678C149DQ30396306-21CBCDF1-8B5D-4A8A-B923-FD5C1CA5A8DCQ30475604-82CD08A9-56ED-44DD-ABE6-8818AEB8A9C3Q33636430-C79438A4-4877-4050-A39B-AE22101E3C0BQ33670499-D5FE0F82-596F-448F-97E3-2DA48B0020ABQ33928304-F2F5E31C-7E09-4A85-864D-28B9AB182AE4Q34036204-A4EEC3C9-2EE5-45B0-8CEC-D0AD200C91ACQ34081598-A8782367-2E6F-4A1C-9F69-C2820431F4F3Q34094198-67D9EDB6-E7E8-4C9F-BC5F-97618D5B82DCQ34177641-9B98A03B-2114-4F1A-B7DE-FC6026140B43Q34437996-1E3DC840-BC32-4ACA-9D1C-3F120B7A2AFFQ34692032-1DCAF51E-97D5-4151-9AF2-9D7D8D8C4E9EQ35873843-DA60C656-BC35-440C-B299-D55AC00588B0Q35964417-B0AB5B82-BDA7-4CAE-A663-1F6CB8E64046Q35970904-0BF974BC-E5EA-4277-918A-9B1279487E30Q36014206-425ACEF2-3EDA-4F32-9424-244E947E5030Q36778444-596BA666-AD33-4FD8-95FE-589C14EC8EB9Q37050960-4D110DB8-121D-4FC3-8070-8E6CCA28C177Q37062125-FF579D81-DD92-4211-9344-800DAE62C1EDQ37194971-DF578671-89C8-430A-ADAC-7C03F0CE7C61Q37287275-3F88F278-9941-402F-86D1-7BCCB34A2762Q37639760-EE0DF6E5-F4C2-4E96-B467-8DFF7F9D6A76Q37689538-99F2257F-2FDF-4633-B1DE-C507A3228A4AQ38012165-F9E7CAD7-4440-468E-B0E3-DF27E6916B69Q38233318-BD68F788-C2CC-465C-B35A-0C7DA4B72B41Q38254723-FFFFAC3B-3085-45BC-A571-8AB2DF0A5AEBQ38755178-587E6689-DBE3-43DD-8A51-BFEDAE94D457Q38832434-A9B550AB-D2F3-488A-82F1-3F0B8EAC8524Q38918124-925B2BE1-47ED-413D-907D-D468E217F5E3Q39259265-6214C9BC-E80D-47D1-A962-C00366299A3FQ39438805-55B85DE7-E0AE-41B0-818B-AF208171FA08Q39546998-8818BCC3-FB15-40BF-97EC-1B49E642C235Q39672500-046D65A5-7851-4664-A842-FC4DFC9FDA0CQ39802190-CD1B3EA3-22F1-4FF6-9DE7-CE86C5D12D58Q41851289-A2FA387D-EA88-4E0B-8927-D3DD129C60D6Q42822804-4B0B28AC-2563-434D-9FC9-47E34C2F179BQ43157185-E4013011-61BF-4AB9-AE81-9145128BB1DFQ43945814-29B61928-5B34-45D6-BE33-2766FFA36E28Q45027324-1EC52073-C4A0-4AE4-AF1A-7A2514AFE683Q45358300-D920BD29-9F68-44FF-A82B-56FF60198EA9
P2860
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
@ast
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
@en
type
label
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
@ast
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
@en
prefLabel
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
@ast
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
@en
P2093
P1476
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
@en
P2093
Auke P Verhaar
Daniel W Hommes
Gijs R van den Brink
Mark Löwenberg
P304
P356
10.1016/J.MOLMED.2007.02.001
P577
2007-02-09T00:00:00Z